| Omics technologies and bio-engineering: volume 1: towards improving quality of life D Barh, VADC Azevedo Academic Press, 2017 | 40 | 2017 |
| Lab-on-a-Chip technology and its applications B Yılmaz, F Yılmaz Omics Technologies and Bio-Engineering, 145-153, 2018 | 39 | 2018 |
| Cancer biomarkers: minimal and noninvasive early diagnosis and prognosis D Barh, A Carpi, M Verma, M Gunduz CRC Press, 2014 | 29 | 2014 |
| Omics approaches in breast cancer D Barh New Delhi: Springer, 2016 | 20 | 2016 |
| Omics Technologies and Bio-Engineering B Yılmaz, F Yılmaz Academic Press, 2018 | 11 | 2018 |
| Noninvasive Molecular Markers in Gynecologic Cancers D Barh, M Gunduz CRC Press, 2015 | 11 | 2015 |
| Expression profiles of the individual genes corresponding to the genes generated by cytotoxicity experiments with bortezomib in multiple myeloma M Ghasemi, S Alpsoy, S Türk, ÜY Malkan, Ş Atakan, İC Haznedaroğlu, ... Turkish Journal of Hematology 33 (4), 286, 2016 | 3 | 2016 |
| Biological System Design Tool, Application Paper MA AĞCA, C TAŞTAN, HS MATAR, B YILMAZ, Y TUNCEL, S ATAOL, ... | 1 | |
| 1339 Systemically administered onco-selective mRNA LNP achieves tumor regression and improves overall survival, as monotherapy R Christmas, J Xu, M Krimmer, Y Rybakova, N Lessard, T Addison, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 827 Onco-selective mRNA-based immunotherapies for modulation of immunosuppressive tumor environment Y Rybakova, A Jakubowski, N Lessard, R Christmas, T Addison, I Muller, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Combination therapy with onco-selective mRNA LNPs targets the complex immunosuppressive tumor microenvironment and is well tolerated at efficacious doses M Kraus, R Christmas, TA Addison, Y Rybakova, L Lee, J Xu, M Krimmer, ... Cancer Research 83 (7_Supplement), 3232-3232, 2023 | | 2023 |
| Precisely engineered stealthy messenger rnas and other polynucleotides Y Erkul, B Yilmaz US Patent App. 17/267,299, 2021 | | 2021 |
| Precisely engineered stealthy messenger rnas and other polynucleotides YE Burak YILMAZ US Patent WO2020033720A1, 2020 | | 2020 |
| In silico Screening and Validation of Immunogenic Viral RNA Sequences G ÇELİK, S Eda, S ÇİĞDEM, CAM ERKUL, B YILMAZ, Y ERKUL Biyoloji Bilimleri Araştırma Dergisi 9 (2), 16-19, 2016 | | 2016 |
| Designing an alternative reporter system for the GFP reporter system using Escherichia coli BL21 strain IY Orhan, HA Karadag, F Bestepe, F Gul, E Uctepe, B Yilmaz Clinical and Investigative Medicine (Online) 38 (4), E228, 2015 | | 2015 |
| Synthetically engineered Bacillus subtilis inhibits growth of Escherichia coli by secreting Limulus polyphemus anti-lipopolysaccharide factor A Guver, B Günbey, FG Yilmaz, H Gungordu, HY Soylu, MS Elitok, ... Clinical and Investigative Medicine (Online) 38 (4), E236, 2015 | | 2015 |
| Biomarkers for Early Detection of Familial Breast Cancer B Yılmaz, CA Moroski-Erkul, OF Hatipoglu, E Gunduz, D Barh, M Gunduz Noninvasive Molecular Markers in Gynecologic Cancers, 167, 2015 | | 2015 |
| Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy D Barh Springer, 2014 | | 2014 |
| Biomarkers in Hodgkin’s Lymphoma EG Esin Demir, Burak Yilmaz, Mehmet Gunduz Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis 1, 2014 | | 2014 |
| Omics of Hereditary Breast Cancer CA Moroski-Erkul, B Yilmaz, E Gunduz, M Gunduz Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis …, 2014 | | 2014 |
Debmalya Barh; Ph.D.Institute of Integrative Omics and Applied Biotechnology (IIOAB), WB, India & UFMG, Brazil確認したメール アドレス: ufmg.br
